Eurofins Animal Health is a leading provider of veterinary contract research services and technical support to the global animal health industry.

We specialise in the design, management and execution of pre-clinical and clinical studies. Our studies can be conducted to the Good Clinical Practice (GCP) or Good Laboratory Practice (GLP) standards, as relevant and as required by our clients.

Our expertise in pre-clinical studies includes the conduct of pharmacokinetic, bioequivalence, residue and animal safety studies.

We have extensive experience in the conduct of clinical efficacy studies on both a small and large scale (i.e. pen and field studies). These are designed for clients to gain marketing authorisation on a global basis. As our primary Animal Health facility is based in Australia, we offer the opportunity to conduct field studies under seasonal conditions of the southern hemisphere which, for example, can accelerate the development programs of northern hemisphere clients.

Efficacy studies with the major production animal parasites are offered, as well as studies to examine the effects of mineral supplements, mycotoxins and agrochemicals. We hold GLP accreditation in Australia (NATA) and New Zealand (IANZ) to meet international regulatory agency expectations for residue depletion studies in a variety of matrices and a broad range of other animal health studies.

Our Animal Health research capabilities include:

• Efficacy studies (e.g. dose determination, dose confirmation, clinical / field studies)
• Target animal safety studies (GCP- or GLP-relevant)
• Residue studies (food-producing species only; GLP-relevant)
• Blood-level Pharmacokinetic and Bioequivalence studies (GCP- or GLP-relevant)
• Palatability studies
• Transfer studies